HFA Premium Access

Mavacamten improves symptoms of shortness of breath in patients with obstructive hypertrophic cardiomyopathy (HCM): analysis of the HCM Symptom Questionnaire in the phase 3 EXPLORER trial

Topic: Hypertrophic Cardiomyopathy

Congress Presentation

About the speaker

Professor Srihari Naidu

New York (United States of America)
0 follower

7 more presentations in this session

Predictive role of myocardial fibrosis and extracellular myocardial volume in sudden cardiac death and ventricular tachyarrhythmias in patients with hypertrophic cardiomyopathy

Speaker: Mrs N. Rineiska (Minsk, BY)


Alcohol septal ablation is safe in young patients

Speaker: Doctor A. Batzner (Wurzburg, DE)


Effects of tafamidis on quantification of myocardial amyloid deposits in patients with transthyretin amyloid cardiomyopathy

Speaker: Doctor R. Rettl (Vienna, AT)


Left atrial strain in cardiac amyloidosis

Speaker: Doctor I. Fabiani (Pisa, IT)


DPD scintigraphy fails to detect transthyretin cardiac amyloidosis in Val30Met mutation carriers with early onset disease.

Speaker: Doctor A. Olivella (Barcelona, ES)


Access the full session

Myocardial Disease

Speakers: Professor S. Naidu, Mrs N. Rineiska, Doctor A. Batzner, Doctor R. Rettl, Doctor I. Fabiani...

About the event


Heart Failure 2021

29 June - 1 July 2021

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb